These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7790036)

  • 21. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.
    Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of human complement regulatory protein CD46 restricts measles virus replication in mouse macrophages.
    Korte-Sarfaty J; Pham VD; Yant S; Hirano A; Wong TC
    Biochem Biophys Res Commun; 1998 Aug; 249(2):432-7. PubMed ID: 9712714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein.
    Hsu EC; Sabatinos S; Hoedemaeker FJ; Rose DR; Richardson CD
    Virology; 1999 Jun; 258(2):314-26. PubMed ID: 10366568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles virus targets DC-SIGN to enhance dendritic cell infection.
    de Witte L; Abt M; Schneider-Schaulies S; van Kooyk Y; Geijtenbeek TB
    J Virol; 2006 Apr; 80(7):3477-86. PubMed ID: 16537615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.
    Hirano A; Kurita-Taniguchi M; Katayama Y; Matsumoto M; Wong TC; Seya T
    J Biochem; 2002 Jul; 132(1):83-91. PubMed ID: 12097164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
    J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46).
    Manchester M; Valsamakis A; Kaufman R; Liszewski MK; Alvarez J; Atkinson JP; Lublin DM; Oldstone MB
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2303-7. PubMed ID: 7534417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails.
    Gerlier D; Loveland B; Varior-Krishnan G; Thorley B; McKenzie IF; Rabourdin-Combe C
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2163-71. PubMed ID: 8077916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of a complementary DNA for a membrane cofactor protein (MCP, CD46)/measles virus receptor on Vero cells and its functional characterization.
    Murakami Y; Seya T; Kurita M; Nagasawa S
    Biol Pharm Bull; 1996 Dec; 19(12):1541-5. PubMed ID: 8996635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
    Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.
    Seya T; Kurita M; Iwata K; Yanagi Y; Tanaka K; Shida K; Hatanaka M; Matsumoto M; Jun S; Hirano A; Ueda S; Nagasawa S
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):135-44. PubMed ID: 9078253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).
    Seya T; Hara T; Matsumoto M; Sugita Y; Akedo H
    J Exp Med; 1990 Dec; 172(6):1673-80. PubMed ID: 2258699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes.
    Seya T; Ballard LL; Bora NS; Kumar V; Cui W; Atkinson JP
    Eur J Immunol; 1988 Aug; 18(8):1289-94. PubMed ID: 3046951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of mutations at the residues R25, D27, P69, and N70 of B95a-MCP on receptor activities for the measles viruses Nagahata wild-type strain and CAM vaccine strain.
    Murakami Y; Fukui A; Seya T; Ueda S; Nagasawa S
    Int J Mol Med; 1999 Jan; 3(1):25-32. PubMed ID: 9864382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.
    Manchester M; Liszewski MK; Atkinson JP; Oldstone MB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2161-5. PubMed ID: 8134365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.
    Oglesby TJ; Allen CJ; Liszewski MK; White DJ; Atkinson JP
    J Exp Med; 1992 Jun; 175(6):1547-51. PubMed ID: 1588280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical association of moesin and CD46 as a receptor complex for measles virus.
    Schneider-Schaulies J; Dunster LM; Schwartz-Albiez R; Krohne G; ter Meulen V
    J Virol; 1995 Apr; 69(4):2248-56. PubMed ID: 7884872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions.
    Seya T; Hirano A; Matsumoto M; Nomura M; Ueda S
    Int J Biochem Cell Biol; 1999 Nov; 31(11):1255-60. PubMed ID: 10605818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering of recombinant soluble CD46: an inhibitor of complement activation.
    Christiansen D; Milland J; Thorley BR; McKenzie IF; Mottram PL; Purcell LJ; Loveland BE
    Immunology; 1996 Mar; 87(3):348-54. PubMed ID: 8778018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.